300 related articles for article (PubMed ID: 26400629)
1. The clinical presentation of attention deficit-hyperactivity disorder (ADHD) in children with 22q11.2 deletion syndrome.
Niarchou M; Martin J; Thapar A; Owen MJ; van den Bree MB
Am J Med Genet B Neuropsychiatr Genet; 2015 Dec; 168(8):730-8. PubMed ID: 26400629
[TBL] [Abstract][Full Text] [Related]
2. Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome.
Niarchou M; Calkins ME; Moore TM; Tang SX; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
Schizophr Bull; 2018 Jun; 44(4):824-833. PubMed ID: 29040797
[TBL] [Abstract][Full Text] [Related]
3. Developmental coordination disorder, psychopathology and IQ in 22q11.2 deletion syndrome.
Cunningham AC; Delport S; Cumines W; Busse M; Linden DEJ; Hall J; Owen MJ; van den Bree MBM
Br J Psychiatry; 2018 Jan; 212(1):27-33. PubMed ID: 29433607
[TBL] [Abstract][Full Text] [Related]
4. Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome.
Niarchou M; Chawner SJRA; Fiksinski A; Vorstman JAS; Maeder J; Schneider M; Eliez S; Armando M; Pontillo M; Vicari S; McDonald-McGinn DM; Emanuel BS; Zackai EH; Bearden CE; Shashi V; Hooper SR; Owen MJ; Gur RE; Wray NR; van den Bree MBM; Thapar A;
Schizophr Res; 2019 Feb; 204():320-325. PubMed ID: 30093352
[TBL] [Abstract][Full Text] [Related]
5. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.
Sobanski E; Banaschewski T; Asherson P; Buitelaar J; Chen W; Franke B; Holtmann M; Krumm B; Sergeant J; Sonuga-Barke E; Stringaris A; Taylor E; Anney R; Ebstein RP; Gill M; Miranda A; Mulas F; Oades RD; Roeyers H; Rothenberger A; Steinhausen HC; Faraone SV
J Child Psychol Psychiatry; 2010 Aug; 51(8):915-23. PubMed ID: 20132417
[TBL] [Abstract][Full Text] [Related]
6. Sleep problems and associations with psychopathology and cognition in young people with 22q11.2 deletion syndrome (22q11.2DS).
Moulding HA; Bartsch U; Hall J; Jones MW; Linden DE; Owen MJ; van den Bree MBM
Psychol Med; 2020 May; 50(7):1191-1202. PubMed ID: 31144615
[TBL] [Abstract][Full Text] [Related]
7. Identifying patterns of anxiety and depression in children with chromosome 22q11.2 deletion syndrome: comorbidity predicts behavioral difficulties and impaired functional communications.
Stephenson DD; Beaton EA; Weems CF; Angkustsiri K; Simon TJ
Behav Brain Res; 2015 Jan; 276():190-8. PubMed ID: 24906195
[TBL] [Abstract][Full Text] [Related]
8. The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome.
Niarchou M; Moore TM; Tang SX; Calkins ME; McDonald-McGuinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
J Psychiatr Res; 2017 Sep; 92():124-131. PubMed ID: 28433949
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
10. Familial clustering of symptoms and disruptive behaviors in multiplex families with attention-deficit/hyperactivity disorder.
Smalley SL; McGough JJ; Del'Homme M; NewDelman J; Gordon E; Kim T; Liu A; McCracken JT
J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1135-43. PubMed ID: 10986810
[TBL] [Abstract][Full Text] [Related]
11. Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects.
Carmel M; Zarchi O; Michaelovsky E; Frisch A; Patya M; Green T; Gothelf D; Weizman A
J Psychiatr Res; 2014 Sep; 56():28-35. PubMed ID: 24853458
[TBL] [Abstract][Full Text] [Related]
12. [Comparing the comorbidity of attention-deficit/hyperactivity disorder in childhood and adolescence].
Keresztény A; Dallos G; Miklósi M; Róka A; Gádoros J; Balázs J
Psychiatr Hung; 2012; 27(3):165-73. PubMed ID: 22781541
[TBL] [Abstract][Full Text] [Related]
13. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
[TBL] [Abstract][Full Text] [Related]
14. Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS.
Michaelovsky E; Gothelf D; Korostishevsky M; Frisch A; Burg M; Carmel M; Steinberg T; Inbar D; Apter A; Weizman A
Int J Neuropsychopharmacol; 2008 May; 11(3):351-63. PubMed ID: 17949513
[TBL] [Abstract][Full Text] [Related]
15. Epilepsy and seizures in young people with 22q11.2 deletion syndrome: Prevalence and links with other neurodevelopmental disorders.
Eaton CB; Thomas RH; Hamandi K; Payne GC; Kerr MP; Linden DEJ; Owen MJ; Cunningham AC; Bartsch U; Struik SS; van den Bree MBM
Epilepsia; 2019 May; 60(5):818-829. PubMed ID: 30977115
[TBL] [Abstract][Full Text] [Related]
16. Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome.
Monks S; Niarchou M; Davies AR; Walters JT; Williams N; Owen MJ; van den Bree MB; Murphy KC
Schizophr Res; 2014 Mar; 153(1-3):231-6. PubMed ID: 24534796
[TBL] [Abstract][Full Text] [Related]
17. Manic symptoms and behavioral dysregulation in youth with velocardiofacial syndrome (22q11.2 deletion syndrome).
Aneja A; Fremont WP; Antshel KM; Faraone SV; AbdulSabur N; Higgins AM; Shprintzen R; Kates WR
J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):105-14. PubMed ID: 17343558
[TBL] [Abstract][Full Text] [Related]
18. Developmental trajectories in 22q11.2 deletion.
Swillen A; McDonald-McGinn D
Am J Med Genet C Semin Med Genet; 2015 Jun; 169(2):172-81. PubMed ID: 25989227
[TBL] [Abstract][Full Text] [Related]
19. Sleep EEG in young people with 22q11.2 deletion syndrome: A cross-sectional study of slow-waves, spindles and correlations with memory and neurodevelopmental symptoms.
Donnelly NA; Bartsch U; Moulding HA; Eaton C; Marston H; Hall JH; Hall J; Owen MJ; van den Bree MBM; Jones MW
Elife; 2022 Aug; 11():. PubMed ID: 36039635
[TBL] [Abstract][Full Text] [Related]
20. Stimulant treatment effectiveness, safety and risk for psychosis in individuals with 22q11.2 deletion syndrome.
Basel D; Mosheva M; Maeder J; Schneider M; Shani S; Weinberger R; Eliez S; Gothelf D
Eur Child Adolesc Psychiatry; 2022 Sep; 31(9):1367-1375. PubMed ID: 33871687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
